- Home
- ASC vs BME Comparison
ASC vs BME Comparison
Compare ASC & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASC | BME |
|---|---|---|
| Founded | 2010 | N/A |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.7M | 547.5M |
| IPO Year | 2013 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ASC | BME |
|---|---|---|
| Price | $16.40 | $42.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 692.0K | 33.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.44 | N/A |
| P/E Ratio | $16.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.32 | $34.18 |
| 52 Week High | $16.00 | $42.63 |
Technical Indicators
Market Signals| Indicator | ASC | BME |
|---|---|---|
| Relative Strength Index (RSI) | 83.55 | 62.92 |
| Support Level | $9.37 | $41.21 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.48 | 0.46 |
| MACD | 0.21 | 0.02 |
| Stochastic Oscillator | 99.14 | 95.57 |
Price Performance
Historical ComparisonAbout ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.